Artificial Intelligence Published on March 25, 2020 Researchers at the Université de Montréal are tackling the genetic characterization of the coronavirus responsible for COVID-19. Read more on La Presse
Medtech Published on March 25, 2020 A device designed by a professor in the Faculty of Medicine and a researcher at the Research Centre of the Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval, could reduce the risk of transmission of the virus among health professionals. Read more on La Tribune
Business environment Published on March 23, 2020 Canada’s plan to mobilize science to fight COVID-19: $275 million for coronavirus research and medical countermeasures is part of the Government of Canada’s more than $1 billion COVID-19 Response Fund. Read more on News Wire
Biotech Pharma Published on March 23, 2020 Quebec government allocates $7 million for the development of Medicago’s COVID-19 vaccine. Read more on News Wire
Pharma Published on March 23, 2020 JAMP Pharma Group, a Canadian pharmaceutical company, announced that it is donating one million doses of hydroxychloroquine to Canadian hospitals, a drug that is normally used to treat malaria and rheumatoid arthritis and which could potentially be useful in treating hospitalized patients infected with the COVID-19 virus. Read more on News Wire
R&D Published on March 23, 2020 The Montreal Heart Institute announces that its Research Centre is launching today a Canadian clinical study to determine whether short-term treatment would reduce the risk of pulmonary complications and death related to VIDOC-19. Read more on Montreal Heart Institute
R&D Published on March 23, 2020 Five Laval University professors receive grants totalling $3.4M from the Canadian Institutes of Health Research for projects to combat VIDOC-19. Read more on Le Soleil
Published on March 22, 2020 Do you know everything Quebec has to offer? Have a look at all the province assets! Read more on our website
R&D Published on March 19, 2020 A researcher from Sherbrooke, Quebec, is part of the team at Moderna, a U.S. biotechnology company based in Cambridge, Massachusetts, which is leading the race for a vaccine against the coronavirus that strikes almost the entire world. Read more on Le Soleil